|
Press Releases |
|
![](/images/company/AdlaiNortye.jpg) |
|
Wednesday, September 8, 2021 |
|
阿诺医药宣布AN2025、AN0025与atezolizumab三联治疗晚期实体瘤1a期临床在美国完成首例患者给药 |
阿诺医药,一家专注于肿瘤治疗领域的创新型全球生物制药公司,今日宣布其口服泛PI3K抑制剂buparlisib(AN2025)、口服EP4拮抗剂(AN0025)与PD-L1抑制剂atezolizumab(阿替利珠单抗)三联疗法在晚期/转移性实体瘤患者中开展的Ia期临床试验已于美国成功完成首例患者给药。 more info >> |
|
阿諾醫藥宣佈AN2025、AN0025與atezolizumab三聯治療晚期實體瘤1a期臨床在美國完成首例患者給藥 |
阿諾醫藥,一家專注於腫瘤治療領域的創新型全球生物製藥公司,今日宣佈其口服泛PI3K抑制劑buparlisib(AN2025)、口服EP4拮抗劑(AN0025)與PD-L1抑制劑atezolizumab(阿替利珠單抗)三聯療法在晚期/轉移性實體瘤患者中開展的Ia期臨床試驗已于美國成功完成首例患者給藥。 more info >> |
|
Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors |
Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced that the first patient has been dosed in the Phase Ia clinical trial in the U.S. to evaluate the triple combination of AN2025 (buparlisib, oral pan-PI3K inhibitor), AN0025 (oral EP4 antagonist) and atezolizumab (PD-L1 inhibitor) in patients with locally advanced/metastatic tumors. more info >> |
|
Thursday, July 15, 2021 |
|
Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management and Tigermed, participated by Legend Star, WuXi Biologics Healthcare Ventures |
Adlai Nortye Ltd. (hereinafter referred to as "Adlai Nortye"), a global biopharmaceutical company focused on developing innovative oncology drugs, today announced the completion of $100 million Series D financing round. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Positive Interim Body Weight Results from Lexaria?s Diabetes Animal Study
Jul 18, 2024 02:07 HKT/SGT
|
|
|
香港书展、运动消闲博览及零食世界今日盛大揭幕
Jul 17, 2024 22:47 HKT/SGT
|
|
|
Hong Kong Book Fair, Sports and Leisure Expo and World of Snacks open today
Jul 17, 2024 22:24 HKT/SGT
|
|
|
香港書展、運動消閒博覽及零食世界今日盛大揭幕
Jul 17, 2024 22:06 HKT/SGT
|
|
|
Dubai AI & Web3 Festival & Trescon Launch FutureTech World Cup to Support Global Start-ups
Jul 17, 2024 21:02 HKT/SGT
|
|
|
ALIT Indonesia empowers marginalized children to improve their standard of living
Jul 17, 2024 16:00 HKT/SGT
|
|
|
New Horizons for SMEs in the Johor-Singapore SEZ
Jul 17, 2024 12:00 HKT/SGT
|
|
|
Save A Train Presents Another New and Unique Addition to its Expanding Global Rail Platform: Rail Forward!
Jul 17, 2024 10:00 HKT/SGT
|
|
|
The Laughing Cow Brings Innovation to Snacking with Delicious Cheez Dippers
Jul 17, 2024 10:00 HKT/SGT
|
|
|
Fujitsu-sponsored professional golfer Ayaka Furue victorious in the Amundi Evian Championship
Jul 16, 2024 23:26 JST
|
|
|
Best BLUETTI Prime Day Deals on Portable Power Stations and Solar Generators
Jul 16, 2024 22:00 HKT/SGT
|
|
|
'Alamein Festival' Launches Exciting Second Edition for 2024
Jul 16, 2024 21:00 HKT/SGT
|
|
|
China Medical System (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating
Jul 16, 2024 21:00: JST
|
|
|
China Medical System (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating
Jul 16, 2024 20:00 HKT/SGT
|
|
|
How Artificial Intelligence Can Help Give Your Business a Boost
Jul 16, 2024 19:30 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|